Could it be that Medtronic may be interested in Poltnovo in the...

Could it be that Medtronic may be interested in Poltnovo in the future? they sure as hell seem to be buying just about anything related to wound care management and other areas that polynovo are working with BTM?

http://www.whatech.com/market-resea...t-market-outlook-to-2020-shared-in-new-report
Australia's wound care management market outlook to 2020 shared in new report

Australia Wound Care Management Market Outlook to 2020 is a new market research publication announced by Reportstack. This report provides key market data on the Australia Wound Care Management market.

The report provides value, in millions of US dollars, and volume (in units) within market categories - Traditional Wound Management, Advanced Wound Management, Negative Pressure Wound Therapy (NPWT), Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags, Compression Therapy, Tissue Engineered - Skin Substitutes, Wound Debridement Devices, Surgical Sutures, Digital Wound Measurement Devices and Hyperbaric Oxygen Chambers.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Care Management market wherever available.

Companies Mentioned
Johnson & Johnson Covidien plc, Smith & Nephew Plc, Coloplast A/S Hollister Incorporated Kinetic Concepts, Inc. ConvaTec Inc. B. Braun Melsungen AG Molnlycke Health Care AB Hill-Rom Holdings, Inc.

ArjoHuntleigh PolyNovo Biomaterials Pty Ltd Medline Industries, Inc. Dynek Pty. Ltd. 3M Health Care Ltd.

Salts Healthcare Limited Pfizer Inc. France Bed Holdings Co.,Ltd. Baxter International Inc.

Livingstone International Pty. Limited

http://www.healthpointcapital.com/r...e_considering_an_acquisition_of_smith_nephew/

Medtronic Reported to be Considering an Acquisition of Smith & Nephew BY ANDREW VAHRADIAN, JUNE 5, 2014

Medtronic to Acquire Covidien for $42.9B BY MATTHEW JAFFE, JUNE 16, 2014


http://www.healthpointcapital.com/research/2014/06/16/medtronic_to_acquire_covidien_for_429b/


Old news I know BUT!
Maybe TPM wasn't quite ready back then ?

http://www.healthpointcapital.com/research/2006/02/13/polynovo_partnering_with_medtronic/

Polynovo Partnering with Medtronic BY SHELLY ACHAIBAR, FEBRUARY 13, 2006

Polynovo Biomaterials signed a partnering and licensing agreement with Medtronic for the development of a drug-eluting polymer stent to treat vascular diseases.
Medtronic will hold equity in the company and pay royalties on the commercialization of the technology.
PolyNovo Biomaterials Pty Ltd (PolyNovo) is an operating division of Xceed Biotechnology Ltd, an Australian Stock exchange listed company (ASX Code: XBL)
PolyNovo is focused on developing a range of biocompatible and biodegradable polymers that will be used in next generation medical devices across multiple therapeutic areas.
The polymer was developed by a team led by Thilak Gunatillake at the Australian Commonwealth Scientific and Industrial Research Organization.
The first application is for a stent to treat vascular disease.
Clinical trails for this application were already conducted on "mini" pigs which have similar biological characteristics to humans.
Additionally, Polynovo has stated its intention to extend into other areas such as spine and is working on the application of its NovoSorb Technology to treat other orthopedic diseases such as osteoarthritis. Given Medtronic's leading position in spine, we suspect this might be a technology platform for Medtronic to develop resorbable, possibly drug- or BMP-eluting, spinal fixation devices, particularly interbody cages.